H1ssF Flu Vaccine Clinical Trial

Summary

This is a two-arm, open-label, randomized, phase 1, controlled clinical trial intended to evaluate the safety and immunologic response to the experimental vaccine H1ssF (H1 stabilized stem ferritin nanoparticle) and the seasonal flu vaccine Flucelvax.

Timeline

Start

2026-08-01

Primary completion

2028-03-01

Completion

2028-03-01

Drugs

Indications